Airocide cleans air from different harmful biological and chemical compounds such as:
• Micro-organisms, viruses, bacteria
• Mold and fungi spores
• Organisms resistant for antibiotics
• Volatile Organic Compouds (VOCs)
Airocide is able to eliminate 99.9% of all the organic compounds flowing through the device.
The technology used in an Airocide is developed by NASA, together with the Wisconsin Center for Space Automation and Robotics from the University of Wisconsin.
The technology has been in use in different space programs, hospitals, food and floral industries and different facilities having challenges with unclean air.
Airocide-device is US FDA Medical device- approved and it also has ETL- and CE- approval.
|Model||GCS – 25||GCS – 50||GCS – 100|
|Measurements||46 × 52 × 11,7 cm||72 × 58 × 11,7 cm||106 × 59 × 11,7 cm|
|Weight||8,1 kg||16,4 kg||27,8 kg|
|Capacity||150 m³||708 m³||1416 m³|
|Ozone production||0,0 mg/m³||0,0 mg/m³||0,0 mg/m³|
|Power||78 W||160 W||360 W|
|EMC||Meets the following settings: EMC per DIN EN 500821-1, DIN EN 50081-2, DIN EN 50082-1 ja DIN EN 55015|
EU Directives – EC EMC (89/339/CEE y 73/23/CE) FDA Class II Listed Medical Device 510 (k) # K023830 Product Code FRA